Awards

The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences.

This year, the ISPOR judges evaluated podium presentations and nominated poster presentations. All podium presentations are considered for an award. Poster presentations in the top 10%, based on abstract review score, are considered and eligible for a poster presentation award. 
Evaluations of scientific merit were based upon the following criteria:

  • Background provides appropriate perspective / context for the subject
  • Objectives / research questions are clearly stated
  • Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
  • Data sources and/or sampling procedures are clear and appropriate
  • Data analyses are appropriate
  • Research objectives are met/addressed
  • Implications of findings are discussed
  • Factual information is kept separate from interpretations or implications
  • Abstract is presented in an unbiased manner
  • Clarity of presentation

THE RECIPIENTS ARE: . . .

ISPOR BEST PODIUM RESEARCH PRESENTATION AWARDS

 

CE1-CLINICAL OUTCOMES AND COST-EFFECTIVENESS OF NOVEL ORAL ANTICOAGULANTS INCORPORATING REAL-WORLD ELDERLY PATIENTS WITH ATRIAL FIBRILLATION 

Zhao YJ1, Lin L1, Zhou HJ1, Khoo AL 1, Tan KT2, Chew AP3, Foo CG4, Oh CT5, Lim WS3, Lim BP1 1Pharmacy and Therapeutics Office, Group Corporate Development, National Healthcare Group, Singapore, Singapore, 2Department of Pharmacy, Tan Tock Seng Hospital, Singapore, Singapore, 3Department of Geriatric Medicine, Tan Tock Seng Hospital, Singapore, Singapore, 4Department of Cardiology, Tan Tock Seng Hospital, Singapore, Singapore, 5Department of Neurology, National Neuroscience Institute, Singapore, Singapore, Singapore

RM4-RELIABILITY AND VALIDITY OF THE HEALTH ASSESSMENT QUESTIONNAIRE (HAQ) IN PATIENTS WITH SPONDYLOARTHRITIS 

Kwan YH1, Yong ST 2, Fong W2, Lui NL2, Malhotra R1, Thumboo J3, Ostbye T1
1Duke-NUS Medical School, Singapore, Singapore, 2Singapore General Hospital, Singapore, Singapore, 3Singhealth, Singapore, Singapore

RM3-COMPARISON OF CAREGIVER-RATED 3-LEVEL EUROQOL-5D (EQ-5D-3L) AND HEALTH UTILITIES INDEX MARK 3 (HUI3) IN PATIENTS WITH DEMENTIA IN SINGAPORE 

Wang VW1, Kandiah N2, Lin X2, Wee HL1
1National University of Singapore, Singapore, Singapore, 2National Neuroscience Institute, Singapore, Singapore

HC4-DERIVATION AND EXTERNAL VALIDATION OF AN EARLY READMISSION RISK PREDICTION MODEL 

Dorajoo SR1, See V1, Chan CT1, Tan ZY2, Koomanan N3, Ong TT4, Razak SM4, Yap CW1, Chan A1
1National University of Singapore, Singapore, Singapore, 2Khoo Teck Puat Hospital, Singapore, Singapore, 3Singapore General Hospital, Singapore, Singapore, 4Temasek Polytechnic, Singapore, Singapore

CU3-LIFE EXPECTANCY, QUALITY-ADJUSTED LIFE YEARS, AND TOTAL LIFETIME COSTS FOR AUSTRALIAN PEOPLE WITH MULTIPLE SCLEROSIS 

Palmer AJ, Taylor B, Van der Mei I, Si L, Ahmad H
University of Tasmania, Hobart, Australia

IN3-EFFECTS OF HBSAG POSITIVITY DURING PREGNANCY ON ADVERSE MATERNAL OUTCOMES: A RETROSPECTIVE DATABASE ANALYSIS 

Tan J1, Sun X2, Liu X3
1School of West China Public Health, Sichuan University, Chengdu, China, 2West China Hospital of Sichuan University, Chengdu, China,3No. 2 West China Hospital of Sichuan University, Chengdu, China


 

ISPOR BEST POSTER RESEARCH PRESENTATION AWARDS

 

PRS1-EFFECTS OF A CHRONIC OBSTRUCTIVE PULMONARY DISEASE INTEGRATED CARE PATHWAY PROGRAMME IN SINGAPORE 

Wu C, Gerald C, Tai KP
JurongHealth, Singapore, Singapore

PRS16-COMPARATIVE EFFECTIVENESS ANALYSIS FOR SMOKING CESSATION MEDICATIONS 

Chang P1, Lo P2, Chang H2, Hsueh K3, Tsai Y2, Lan T4
1Department of Medicine, Stanford University School of Medicine, California, CA, USA, 2Institute of Health and Welfare Policy, National Yang-Ming University, Taipei, Taiwan, 3Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, 4Center for Geriatrics and Gerontology Taichung Veterans General Hospital, Taichung, Taiwan

PCV24-COST–EFFECTIVENESS OF DIFFERENT STRATEGIES FOR PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT IN CHINA 

Yan XY1, Gu XH2, Zhou L3, Lin HW3, Wu B4
1Department of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China, 2Department of Respiratory, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China, 3Department of Cardiology, Renji Hospital, Shanghai, China, 4Medical Decision and Economic Group, Department of Pharmacy, Renji Hospital, Shanghai, China

PHP33-CONSTRUCTION OF SYSTEM DYNAMICS MODEL FOR MEDICAL CARE SYSTEM OF JAPAN 

Inoue S1, Xu H2, Maswana J2, Kobayashi M1
1CRECON Medical Assessment Inc., Tokyo, Japan, 2University of Tsukuba, Tokyo, Japan

PSY18-THE ASSOCIATION WITH PSYCHIATRIC DISEASES AND PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA IN TAIWAN 

Chang C1, Chu C2, Tang C1
1Taipei Medical University, Taipei, Taiwan, 2National Taiwan University Hospital, Taipei, Taiwan

PMH8-ESTIMATING THE ECONOMIC BURDEN OF TREATMENT RESISTANT DEPRESSION IN TAIWAN USING THE NHIRD 

Klug J1, Yu F2, Chang C3, Juang H4, Wang M5, Fife D6, Liu C4, Wang BC7
1Janssen Asia Pacific, Kowloon, Hong Kong, 2Janssen Asia Pacific, Beijing, China, 3Chang Gung University, TaoYuan, Taiwan, 4Chang Gung Memorial Hospital, Tao-Yun, Taiwan, 5Janssen Taiwan, Taipei, Taiwan, 6Janssen, pharmaceutical company of Johnson and Johnson, Titusville, NJ, USA, 7Elysia Group Ltd, Taipei, Taiwan


ISPOR would like to thank all the judges who have volunteered their time and efforts during the meeting to score podium and poster research presentations.